CD28 and B-cell chronic lymphocytic leukemia: In a phase I trial, however, a treatment-related death of an extensively pre-treated CLL patient occurred shortly after lymphodepletion and infusion of CD28-CD3ζ CAR T cells at a total dose of 3 × 107 T cells per kg [53].